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The Unfinished Legacy of Liver Transplantation: 
Emphasis on Immunology 
Thomas E. Starzl and Fadi G, Lakkis 
Liver transplantation radically changed the philosophy of hepatology practice, enriched 
multiple areas of basic science, and had pervasive ripple effects in law, public policy, ethics, 
and theology. Why organ engraftment was feasible remained enigmatic, however, until the 
discovery in 1992 of donor leukocyte microchimerism in long-surviving liver, and other 
kinds of organ recipients. Following this discovery, the leukocyte chimerism-associated 
mechanisms were elucidated that directly linked organ and bone marrow transplantation 
and eventually clarified the relationship of transplantation immunology to the immunology 
of infections, neoplasms, and autoimmune disorders. We describe here how the initially 
controversial paradigm shift mandated revisions of cherished dogmas. With the fresh in-
sight, the reasons for numerous inexplicable phenomena of transplantation either became 
obvious or have become susceptible to discriminate experimental testing. The therapeutic 
implications of the "new immunology" in hepatology and in other medical disciplines, have 
only begun to be explored. Apart from immunology, physiologic investigations of liver 
transplantation have resulted in the discovery of growth factors (beginning with insulin) that 
are involved in the regulation of liver size, ultrastructure, function, and the capacity for 
regeneration. Such studies have partially explained functional and hormonal relationships of 
different abdominal organs, and ultimately they led to the cure or palliation by liver trans-
plantation of more than 2 dozen hepatic-based inborn errors of metabolism. Liver trans-
plantation should not be viewed as a purely technologic achievement, but rather as a 
searchlight whose beams have penetrated the murky mist of the past, and continue to 
potentially illuminate the future. (HEPATOLOGY 2006;43:S151-S163.) 
L q;au,: plfl1~rhil1g immat~riai as a st\."le or philoso-ph\" that is p,lssed fiul1l one gc'nl'J'ati()1l (0 another, 
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in til<: de\'Clopmenr and USe of this procedure Iud been 
rc'ached be(\\'CL'n I')";"; and 1()xO (I',lhlc 1),1\(, The 
prodigious task (hat Lt\ ahead in 19S 1 was diffusion of 
the complex new ll1ultidisciplinan" l'l1tnprise into the 
nation~d ,1l1d international healthcare systcms (Table 
l).i" i Thc extent [() which this was accomplished is 
evident in the 2004 Anion Plan for l.iver [)i,e,lSl' Re-
\c,lrch designcd to ", ,coordinatl' r('scHeh efforts ito 
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Research and Development Opportunities 
The NIH pLlI1 was di\'ided into 1(, ch;lptCrs, on~ ofwhich 
was devoted cxclusivek to liver transplantatioIJ, with pri-
mary emphasis on clinical rcsearch, The li\'er transplant 
chapter began with the simple declarative scntcnce, "I.iver 
tr<lI1splanratioIJ is IJO\\ the standard of care t()r patients with 
end ,cage li\'er discase or ,\elltC liwr Llilure," 'It was a proud 
q;l[l'll1enr ti"oll1 dll' gmcrnmenr agenc: \\hosc unbiling sup-
port had made this possibk. Rut, had liver transplalltatioll 
matured so completely that theTe is nothing Idi to do hut 


















































Table 1. Milestones of Liver Transplantation 
Description 
First article In the literature on auxiliary liver transplantation 
Concept of liver replacement first mentIOned 
Results reported of canine total hepatectomy and liver replacement without immunosuppression 
Abdominal multivisceral transplantation described in non-immunosuppressed dogs 
Azathioprine-prednisone cocktail introduced (kidneys first. then livers) and recognition of organ-induced tolerance 
Description of In Situ preservation and procurement of cadavenc organs 
First attempts to transplant the human liver 
Evidence reported of hepatotrophic (liver-supporting) factor(s) in portal venous blood 
Liver-induced tolerance under a short course of azathioprine reported in dogs 
First liver xenotransplantation on July 15. 1966 (chimpanzee donor) 
Clinical introduction of ALG for kidney. then liver recipients 
Evidence that HLA matching would not be a major factor In cadaveric organ transplantation 
First I-year survivals after human liver replacements 
Acceptance of brain death concept 
Liver-induced tolerance in pigs without immunosuppression 
First textbook of liver transplantation based on 25 Denver cases 
First palliation (or cure) of inborn error of metabolism with liver transplantation 
Evidence accrued that the liver controls cholesterol homeostasis 
Description of the liver's resistance to antibody-mediated rejection 
PrinCipal portal blood hepatotrophic factor identified as insulin 
Causes of failure analyzed in first 93 Colorado cases of liver transplantation 
Improved slush liver preservation permitted long-distance procurement 
Systematic use of arterial and venous grafts for cadaver liver revascularization 
Cyclosporine introduced for organ transplantation including 2 liver recipients 
Cyclosporine-steroid cocktail introduced clinically 
80% I-year liver recipient survival reported using cyclosporine-prednisone 
Review of progress in liver transplantation generates widespread interest of hepatologists 
Introduction of pump-driven venovenous bypass without anticoagulation 
USA consensus development conference conclusion that liver transplantation is a service (1983) IS followed by 
rapid proliferation of transplant centers worldWide 
Standardization of in situ preservation-procurement techniques for cadaver multiple organ donors 
Reversibility reported of B cell malignanCies (PTLD) In liver and other organ recipients 
Reports of reduced-size liver grafts for pediatnc recipients 
Liver transplantation of patient with hypercholesterolemia verified hypothesis that the liver is the site of 
cholesterol homeostasis 
First successful transplantation of liver-containing muitivisceral grafts 
UniverSity of Wisconsin (UW) solution improves preservation of liver and other organs 
Successful extensive use of livers from "marginal" donors reported 
National adoption of Pittsburgh point system for cadaver kidney and liver distribution complies with Organ 
Transplant Act of 1984 
Popularization of the "piggyback" variation of liver transplantation 
Clinical introduction of FK 506-(tacrolimus)-based immunosuppression 
First report of split cadaver liver for transplantation into 2 recipients 
First use of live liver donors (left side fragments) 
Discovery of donor leukocyte microchimensm in liver (and other organ) recipients. placing organ and bone 
marrow cell transplantation on common ground. 
Delineation of analogies between transplantation and infection Immunology 
Live donor transplantation of right side liver fragments 
Mechanism-based tolerogemc immunosuppression proposed 
Double knockout of porcine n1.3GT gene. revitalizlflg hopes of clinical xenotransplantation 
Clinical use of tolerogenic immunosuppression 
Mechanisms of recurrent hepatitis under transplant immunosuppression elucidated. 


















































tation in almost all of the 1') other chapters of the NIH 
prospectus. Most of these links were to targets of research 
opportunity that already had been enriched by. or even owed 
their provenance to. liver transplantation. 
for example. techniques of liver procurement. preser-
vation. and replacement are currenrly being adapted in 
non-transplant circumstances (e.g .. for subtotal hepatic 
resections). The discovery that portal venous blood con-
tains substances important for maintenance of I iver size. 
function. and the capacity for regeneration was the begin-
ning of the still-evolving special field of hepatotrophic 
physiology that is concerned with the functional and hor-
monal interrelationships of the different splanchnic or-
gansK-D·fKI~·F·yEf·-I~"- The hepatotrophic studies ultimately led 
1-I1 1',\\l)I()(.\, \ ,,1 1 \, '-." , " "1'1'1. \ ~1f1iE I 
ro rhe cure or fF~dliarion wirh liver l'epLtcemcnr or iHliller-
(lLIS hep~llic-h ~lsed inborn errors of' mcraholi s mI :;KO f~ H 
IH(lViciin[!, rhe first D:-"~11l111 f es 01' \\h,ll might be ,1CC0I11-
J11ished in rhe f'ururc \\irh gCl)(' rhcrapy ,lnd rhe applica-
rion or Srel11 cell hiology, rinallv. religious beliefs, 
w ncuns 'lhour Il1edicalethics, ,1nJ public po li cy or legal 
iSSLICS rhar slIl{lced 4 decades agu \\iirh rhe fir ::. r arremprs or 
liver rranspl;lIlurion" -'I,'" remain as unresolved agenda 
i rems in rhe NIH masrer plan of 2004, 
H(l\\Clcr, rhe most i'rcqllenrl: idcnriflcd porcnriaJ re-
::.Glrch in i riari ves in rhe :.J I H srrarqo;ic plan of 2004 con-
cerncd rhe iml11une response or rhe l11;lJ)irt)ld consequence.' 
of nlOdiking ir, nU[ lusr for rransplanrarion bur also in rhc 
conrexr of hcp,lriri", Hl\ ', and oncology (ro which separ,1[e 
ch ,lprCls of rhe pl'lI1 \Vere devmed), Using roEhyD~ sophisri-
ured [(lob (panieulark rhose or ll10lecubr biology}, ir 110W 
)11;1)' be pO\sible [() CX 11;lI1d rhe sphere ut'immunology in new 
din.:uiolls, fill in knowledge gaps, cxpbin long-sranding 
cnigmas, and conrrihlltl' ulrimaleh- ro burn p,lrienr em:, 
\\/ irl1 rhis ill mind, ri1e fo ll owing discuss ion considers spc-
cinc issues of' immiillolo~Dy D rh :lr ~lfe cenrral [0 rhe furrh er 
dcvelo[llllcnr orlivcr uanSpLll1r;lrion and [0 ill1provemem of 
rrC;nllll'IH LinckI' mulriple lloncr;lnspl;lIH CirCllll1SranCes, 
The Relation of Alloengraftment to 
Acquired Immune Tolerance: The Historical 
View 
Bone Marrow Transplantation. qfDan s pl ;l nl ~eion 
i 111111 II llol0t!Y W;IS brllligh l w irs curt'ell( sr<lrc hI' a seri es of 
evems rh ;n heg,ll1 in 194IF- /~4 wilh ,\!Itdawar's demonsrra-
lion rh,n I'ejecrion is ;111 immune res pEFf1~cKD ,,\ I'ell' I;ncr, 
Owel1 discovered mixed blood ce ll chimerism in hw'-
marrin Clrrie whose fu sed placem;ls had pcrmirred fer,ll 
CEEFsp-Circllhriofl ~D : SLieh ,1l1 imals were suhsequl'lllk 
shown co ht' nlllw;dh' wln,lnl, T hen, in 19')')-')') , rhe 
strong associ;1rioll of donor lcukocl'cc chimerism :ln d ;lC-
lJllired dOllur- sl)t'ci hl wlerancc v,cas demollsu<1red in cx-
perill1Cllr S in which allogcneic 'Ill ecn and bone 1ll:1rrow 
cdls were rransplamcd wirhoul iIl1l1l111l0SUppres"iol1 itHO 
il111l1ul1Oiogicdly in1g ll~FEure mice'" ,llld ifl(o irradiared 
~ld ul r I1lOU,e rccirien r., .sl AJrC[' hem~eolyIl1lphopoieric ,-cll 
cl1f,!;I'afrn1L' m, rhc n:cif1iellrs could accepr all orher dOllor 
rissue~ and ol'gans, ' rile mOllse w krance modl'ls eSGlbred 
OVCl' lh(' L'J1S11il1g 1') : 'l';HS [(l cl iniClI bOlle marrow rr,lIlS-
planr'H iOIl ill i 111 111 llJ10deficiclH and irradi,l[l'd parienrs, 
Howcver , success dCJlCnded on rhe lise of' H LA-marched 
donors, Orherwi se, rile 11en:dl: f(')r engr;lfcmenr was lc'til ,ll 
gr;1CI -vcrslis-hosr di \l',lse (CVHD): I'clectlon of rhc hosr 
lw rhe grJlt, 
Organ Transplantation. In COnlr;lS( to rhL' "hc llch 
ro hc:clside" chf'Ollo logv of hOl1e marrow rl'an sf1\;ul[ ,uion , 
~ Im munosuppce .. ;on 
Failure 
(Irrev.,..lbll'ril!'Jection) 
Reclpi.nl ....... , ........ " 
.................................................. , 
TIme after Organ Transplantation 
Fig, 1. Contemporaneous host-verSlls,grah (HVG) and graft-versus, 
host (GVH) immune responses after transplantat ion , The presence of the 
weaker GVH response in organ rec ipients (tile Inverted curves on a gray 
backgro und) was nol recognized until the discovery of microchlmerism in 
1 99OI i:eS~ However, the demonstration in 1962- 63 6 that the HVG 
response (rejection ) IS reverSible and may be succeeded by a slate of 
variable tolerance (yel low panel) allowed the practical development of 
immunosuppression aided clinica l organ transplantation 
organ run sphflr<lcion (inil'ia ll y of rhe kidney) was accom-
plished in humam K' ~r I hefore prooFoHcdsibilir;' was dem-
on srrated in an ~1ilil11all1lodel and in rhe ,1pparelH absence 
() r Icukoeyre eh i 111 crisll1 , The fi rsr 6 kid ney recipienrs wi rh 
prolonged grafr surviva l ( J 959-19( 2) were IHeconJi-
riuned \,v[rh suhlnhal wral body irr;llkllion bur \vere nor 
infused \virh donor bonc marrow ecllKII DDD e~ In 1960-61, 
daily posr-rrgnsp l ~1nrarion Jzarhio[Jrine was shown [0 pro-
long kidnc; ' survival in dEFg s ~D F ,md raken ro c1inicd fI'I,1k 
U cd ;done 0 1' wirh mher c),(Oroxic ,11;eI1[S, ;l/clrhioprille 
was only 111,1I'ginall)' eFfecrive ."" ·' 1 HowevCl', irs cOl11bin<1-
rion wirh prednison e made renal rr;1nsplanl<lrion :l prac-
ricd servicc by exposing 2 fearures of rhe :d loill1lllunc 
response" rhar lartr were demonsrra(ed w irh li\'er and all 
orher kinds of organ u<lI1splal1rJlion and unde r clll orher 
I'egimens of- immunosupprcssion, 
I 'he fi rsr unex plai ned observarion was rh,n rejceriolls 
riUl developed under JZ<lriliopri ne \VCI'C clsih' reversed 
wirh rhe addirion of large doses of' prednisone Lnhcr d1,11l 
heing incxorable ;lS previollslv rhought. Second, a success-
ful reJecrion re vcrs~d frequcn r1y t<l~ ~ ui iiDcded [1\' ~f grearl v 
reduced rcquiremenr fo r 111<linren~1nc tD immunosuppres-
sion (hg, 1). sLiggesr ing rhM rhe gu i'( was inherenrly 
wierogt' nic" J l also \\,1\ IClI'ned rhar h isroeom p;Hibii irv 
marching was nor a prerequisire fo r ,SllccesS, char rhl'fc' was 
lirrle rhrear of CVHD , and rhar perperuarion of organ 
gra fr survi val almos( alw;1Ys depend eJ on liferime drug 
(l'L\UI11CIlf. [n .lddirion ro rhese srriking differences from 
bone TllMro\\' rL1I1SpL111[;nion, none or' rhe organ recipi-
C IUS were rhoughl ((l k1Vt donor Ieukocyre ch im erism 
(Table 2) 
Table 2. Differences Between Clinical Organ Transplantation 
and Bone Marrow Transplantation 
Transplantation Marrow Transplantation 
Feature Organ Bone 
Host cytoablatlon No Yes' 
HLA matching Not essential Critical 
Principal complication Rejection Graft-versus-host disease 
ImmunosuppresSIOn-free Uncommon Common 
Term for success Acceptance Tolerance 
Leukocyte chimerism No Yes 
Abreviatron: HLA, human leukocyte antigen, 
'This therapeutic step allows a relatively unopposed graft-versus-host reaction 
and accounts for the other differences, 
Because ofthese striking disparities, onran enaraftmenr 
L u b 
and successful bone marrow transplantation were consid-
ered for many vears to involve fundamemallv different 
mechanisms .. Experimental therapeutic strat~gies were 
empiricallv developed with the objective of endowina Of-
. 0 
gan recipients with the donor leukocyte chimerism-asso-
ci~eed mechanisms of the bone marrow recipient while 
<In)iding the penaln' of GVHD.'",q, These srrate-
gies"""-"- had in common the infusion of donor hema-
tolymphopoietic cells into organ recipients that had been 
immunologically weakened by irradiation, anrilymphoid 
antibodv preparations, or other means (i.e., non-mvelo-
toxic cnoreductiol1). Al though encour;wing experi ~len-
, b L 
ral results have been reported,')K,.,.) such protocols have nor 
fOllnd a significant niche in clinical or"an transplantation 
c 0 
practice because of their complexity, risks, and unpredict-
able consequences. 
Nevertheless, this bodv of experimenral work demon-
strated that the establishment of a hemarolymphopoietic 
population composed of donor and recipient cells was 
possible in some models with a reasonably low risk of 
C;VHD and could result in donor-specific tolerance, pro-
viding the donor cell contriburion was at least 1 % to 2(Yn 
C'macrochimerism"). Levels below this ("microchimer-
ism ") were inrerpreteJ ~lp ei ther negative f-i nd ings or arti-
L1CtS. B\· so doing, rhe historical paradiam that attributed 
, 0 
bone marrow and organ engraftment to differenr mecha-
nisms required no substantive revision. 
A Unification of Bone Marrow and Organ 
Transplantation 
The historical paradigm was not challenged until 
1992. When small numbers of mulrilineage donor hema-
lOlvmphopoietic cells (microchimerism) were found in 
clnimal and human recif)ients of IOI1<T-survivina kidney o b ~ 
and liver allografrs",,,,'I(lO I02it was postulated that the 
mechanisms of organ engraftmenr ditfered only in degree 
from the leukocyte chimerism-dependent ones ofsuccess-
ful bone marrow transplantation. Organ engra!lll1ent was 
HFI' __ \ II lil ley. h'hrLwI 2()()(, 
now defined as a variable form of tolerance that resulted 
from " ... responses of coexisting donor and recipient im-
mllne cells, each to the other, causing reciprocal clonal 
expansion followed by peripheral clonal deletion,"'.;", 
The graft-versus-host arm of the double immune reaction 
(the inverted curve in Fig. 1) usually was clinically inap-
parent. 
The prerequisite tor the donor-specific tolerance was 
migration of the graft's passenger leukocytes to host lym-
phoid organs and induction there of the host-versus-graft 
response. Because the multilineage passenger leuko~ytes 
of an organ are of bone marrow origin, their hematoge-
nous migration into the recipient was in essence the 
equivalent of a bone marrow cell infusion. Exhaustion 
and deletion of the anridonor response explained the 
characteristic rejection reversal and subseljuent decline in 
need fIX immunosuppression in organ recipients (Fig. 1). 
Cytoablation of bone marrow, but not of organ recipi-
ents, was the apparent reason tor essentially all of the 
diHerences between the two kinds of transpi~ntationI in-
cluding the high risk to the bone marrow recipient of 
C\,HD, and the need to restrict marrow donors to those 
with a histocompatibility match HI' (Table 2). Essentially 
all cytoablated bone marrow recipients have a small resid-
ual population of their own hematolymphopoietic cells 
(i.e" mirror image microchimerism) rather rhan complcre 
bone marrow replaccl11en t. HI" 
Th is unified view of rransplamation v,'as conrrover-
"I'INI'h"III)' b " '1.1 'Id sla, , In part ecause It was Il1compatlo e Wit 1 og-
mas that made up much of the foundation of 
transplantation immunology. One point of contention 
was our view that hisroricallv rooted alternative enaraft:-
. 0 
l11cnr mechanisms (listed in Table .)) welT either epiphe-
nomena or "variants or stages" of the clEFn~d exhaustion-
deletion thar followed the key event of leukocvte 
migration.'" In addition, the role of small numbers' of 
persistent cells (the microchimerism) in perpetuation of 
long-term graft survival was not vet clear. Finallv, the 
crucial mechanism of clonal exhau~tion-deletion W:1S still 
Table 3. Mechanisms of Immune Nonreactivity* 
Essential 
(1) Clonal exhaustion-deletion 
(2) Immune Ignorance 
Alternative 
(1) SpeCial recipient cells: T-regulatory, suppressor, veto 
(2) Antibodies: Idiotypic, "enhanCing" 
(3) Cytokines: Self-perpetuating combinations 
(4) Inhibitory molecules Down-regulation 
(5) Graft secretions Soluble HLA antigens 
(6) Antigen presentation: Defective or deViant 
(7) Anergy Absence of second Signal; or cytokine exhaustion 
'Modified from Starzl TE. J Am Coil Surg 2005:201:160-170. Reprrnted with 
permiSSion, 
· . 
~1fgD 1D1K ! , 20tl(, 
gCllcrally considered ro he only a rheory, Alrhough we did 
nor kllOw ir ,lr rhe rime. precisely rhese issues were being 
;lddressed indepel1dcnrl:' in Zurich bur in rhe conrexr of 
immune resronsivcness and unresponsiveness [0 non-cy-
rorarh ic microparasi res (see he low) , 
Tolerance From the Infection Perspective 
The nHJO r h isrocom paribili ry complex-resrricred 
ll1echanisll1~ of -1 cell recognirion oF. and response [0, 
noncyrop;trhic microorganisms. and ro allografrs. had 
oeen elucidared by Zinkernagel and Dougherry in rhe 
1l)70s. I II I I ' bu r rhe l11echan isms of acq ui red im m une 
nonreacrivirv remJincd a puzzle, Dming rhe earlv J 9905, 
Linkernagcl and his associares in Zurich formally proved 
in mouse infecrion models rhar rhe anri-parhogen T cell 
re'pon.se could be exhausrcd and delered l' " and con-
cluded rh;lr rhis was rhe explan'lrion for rhe carrier sra re 
rhar nlay dcvelop afrer infecrion wirh noncyroparhic (in-
rr~lCelllllarF viruses, I I , As wirh rral,lsplanrarion, rhe crirical 
srep was migrarion of rhe parhogen or irs pep ride ro hosr 
Ivmphoid organs, The presence of virus rhar Eliled ro 
reach rhese desrinarions was nor recognized by rhe hosL 
This was rermed immune indifference (now called im-
mune ignOl'an ce) _ In e,,> ence, Zinkernagel er al. had clar-
ified rhe inrerrelari(lnship of immuniry and rolerance ro 
parhogens. and h"d defined rolerance in rerms of rwo 
eA~e nri ;ll l1lech;llli sms: inlmune ignorance and clonal ex-
hausrion delerion Moreover, rhey placed rhese mecha-
nisms in the same dvnamic conrexr of anr igen migrarion 
as rhar of rLlnspbnrarion_ II ' 
Once rhe viral anrigen reached lymphoid desrinarions 
;mel induced ;\ cyro\vtic T Iymp hocyre (CTL) response, 
rhe ourcomes in rhe highly conrrolled models oflympho-
cyric choriomeningiris virus (LCMV) infecrion were de-
rermined hy rhe balance bcrween rhe amounr of yirus 
anrigcn and rhe number of induced anrlgen-specific 
CT , I I ; Analogous [0 rhe maximal Rood of passenger 
leukocvres migraring from a transplanred orgJ.n , rhe crir-
iCll reriod was during rhe firsr few days or weeks of' viral 
repliclrioll, If rhe CfL were induced in surf] ienr num-
bers. rhc resulr was disease conrrol; if nor, rhe resulr was 
clonal exhausrion-delerion and a carrier syndrome rhar 
ranged r'rol1l ;lsymprol1laric ro progressively more serious 
di seast' srarcs, No maner wh,1( balance was esrabl ished 
;teurelv. perperuarion of rhis balance (wherher immuni ry, 
delerion;t\ wlerance. or some srage in berween) depended 
on persisrencc of ;)nr igen wirh access ro hosr lymphoid 
organs, T he abiliry oh mall amounrs of persisrent virus ro 
survive was ;ltuibured ro irs relocarion In non-lymphoid 
sires rhal were in;\n ;cssible ro hosr immune effecror mech-
anisms, '" From rhese pro[ecred niches. rhe virlls mi-
grated sClondarik [() hosr Ivmphoid organs and could 
Fig, 2, The consequences of antigen spread and loca lization (see 
text ): (A) with liver or other kinds of organ transplantation; (B) with a viral 
Ilepatitis infection; (C) with a human immunodeficiency virus (H IV ) 
infection ; (D) with a pulmonary cytomegalovirus infection 
sustain immuniry, 01- alrernarively, 1ll<l11H<lln rolerance, 
1'h us, persisrcnr J nrigen was <l rwo-edged sword, 
The Boundary Between Immunity and 
Tolerance 
The analogies berween transplan urion and infecrion 
were summarized in 1998 and generalized [() orher 
branches of immunologv in rhe following sraremenr: 
_Migrarion and localizarion are rhe governing facrors 
in immunologic responsiveness or unresponsivene.s 
againsr infecrions, rumors dnd self. and againsr xenoaraFrs 
L ~ b 
and allografrs, " 1,(, All of the clinical scenarios of rransplan-
rarion, and those resulring from infec rion h;' noncyro-
pdrhic parhogens, could be correlared wirh rhe roures of 
migrarion and rhe ulrimare localizarion of rhe respecrive 
;lllrigens, The "gray area" berween unequivocal immuniry 
and durable rolerallce included a diversity of rransplanr 
ouccomes shorr of our righr acure irreversible rejecrion, as 
",-ell as a panoply of analogous virus carrier srares; all rep-
resenred differenr degrees of panial rolerilnce_ Such im-
munologic "compromises" included chronic allografr 
rejecrion and irs analog. chronic hepariris, "" 
The Rejection Option 
Organ Transplantation. The dmigcn migrarion is 
essenrially rhe sa me wirh rransplanrarion of rile li ver and 
anv orher surgically revascularized whole organ (Fig, 2A), 
Moven1enr of rhe passenger leukon'res is selecrive ar fim 
ro hosr Ivmphoid organs. where a cloll:!1 anridollor T cell 
resronse is ind uced, l'he CTL rhen rarger rhe rrans-
planted organ as well as the peripheralized cells of the 
sourcc graft (Fig. 2A). 
Infection. The migratory principles after infection by 
noncywpathic microparasites are the same as those of 
passenger leukocytes, but the details ditter because both 
the pathwa\'s of microorganism migration and the targets 
of the CTL response arc dictated by the tropism of the 
varioLls pathogens (rig. 2B-D). for example, hecause of 
the liver tropism of the hepatitis viruses, the quantity of 
viral antigen that migrates to host lymphoid organs is 
small compared with that homing to the liver (Fig. 2B). 
At the lymphoid organs, hepatitis virus-specific CTL are 
induced L)\' infected antigen-prcsenting cells (APC) dis-
pla~Ding complexes of major histocompatibility complex 
molecules plus pep tides derived from the pathogen. Bc-
caLIse the induced CTL then destroy infected host cells no 
matter whLTe these "non-self" cells art' located, the prin-
cipal discv.,c expression is hepatic (Fig. 2B). IntCctions 
with other intracdlular \iruses (Fig. 2C-D) are yI~lri;ltions 
on the same theme (see later discussion). 
The Tolerance Option Without Immunosuppression 
Organ Transplantation. Exceptions to the outcotlle 
ofiml1lunity (i,!'" rejection) in untreated transplant recip-
iCIH) ~lfq rare. However. lifetime rolerancc to liH'r allo-
grafts OCCLlrs without therapeuric manipulation 111 
approx imateh' 2()'Yo of otttbred pig recipients "'_'II ~ I <>.1 l-
and with ne;l1-ly 100°" regularit;· using selected donor-
rccipient r~lt strain combinations, I Is I'll and most mousc 
srrain clll1bin~ltionsK" 1 Less well leukocvte-endowed 
IllOllSC hean:' I 1 -~-D and kid ney allografts I'; also rdiahly 
self-induce tolerance, although in fIr fewer strain combi-
nations. These models of spontaneous transplantation 
wleranct' dcmonstrate that graft-induced imlllunc l1on-
reactivity is a normal potential option of the immune 
respollse (Fig. :\A). Importantk, the "spontaneolls roler-
;lI1ce" may be abrogated in some of these models by ad-
III i n isteri ng i 111m u nosuppression. I CI I cs 
Infection. Afrer most infections lw 11OI1C;'rop;lthic 
parasires, th~· balance hetween antigen and amigen-spe-
Lillc err. tilrs within a tew weeks [0 immunity. The ex-
ception;; in which protective immunity frcquemk does 
not develop constitute a collection of some of the world's 
most difficulr-to-treat diseases [e.g., ~lCquired imlllune dc-
hcienc\' syndrome (AIDS), hepatitis, and malaria!. 
Therapeutic Implications 
Infections With Noncytopathic Microorganisms 
In 19')4, Zinkernagel and Hengartner discllssed the 
compararive pathopf1\'siology of HIV (a retrovirus) and 
hepatitis B \'irus EeByD~ a O\:A virus) in the context 
largely developed with their studies of the l.CMV (all 
A 
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Fig. 3. Organ-Induced tolerance, (A) Spontaneous tolerance Induced 
by the liver in experimental models 1k )111k ILl In which the host-versus-
graft Immune response Induced by the migratory donor leukocytes is too 
weak to eliminate the donor antigen and is exhausted and deleted (the 
rise and fall of the continuous thin line), Maintenance of engraftment 
depends on small numbers of perSistent donor leukocytes (mlcrochimer-
Ism), The less well-leukocyte-endowed heart and kidney also can "self 
;nduce" engraftment but in a much smaller number of models. (8) 
Immunosuppression-aided tolerance In organ transplantation models In 
which the recipient response that normally would cause rejection 
(dashed line) is reduced into a deletable range (continuous thin line) 
With a short course of early post-transplantation Immunosuppression. 
lifetime tolerance after stoPPing ImmunosuppreSSion was first convinc-
ingly demonstrated in canine liver reclpients. 1 ·. (C) A self-defeating 
consequence of excessive prophylactiC over-immunosuppression (de-
picted with multilayered bars) that subverts efficient clonal exhaustlon-
deletloll, The initially over-treated recipient may be committed to 
unnecessarily high maintenance immunosuppression. This undeSirable 
effect of too mucll Immunosuppression was not recognized until 2001 70 
Tx ~ Transplantation 
RNA virus). The aurhors <lrgued that rhe cOllsequenccs of 
H IV were caused pri ncipall~D bv virus-speci fic c\'t()(oxic T 
cell-mediated immunoparhology rarher than In' direct 
c\'tolvtic eHects or any other mechanisl1l. I -'" The es<,ellce 
. . 
oftheir argument is shown in Fig. 2C. K~ytter HIV antigen 
deliverv ro lymphoid organs by intec[ed dendritic cells or 
other AP(:, a CIT responsc' is induced that target, (:1)4 
(T helper) and all other infected cells. \X'ith the selective 
destrllction of infected CD4 cells and eventual decinu-
(ion of thc~ infected APe: popubriol1, rhe ill;ltiequalely 
renewed HIV-specific cn. clone is easih- exhausted and 
delcted lnd, eventually, the entire CTL population dwin-
dles. Thus, thc immunodcflciency of AIDS mil\' be prc-
vCIHt:d ~ll [he outset hy a strong C:TL responsc, or 
altertl.llin:h. thc re~ponse may Clllse immunodeficiency. 
The outcome tj'om the events shown in Fig. 2C depend~ 
on the balance established at an earlv time between the 
.lmounr and localization of the virus versus the (:TL re-
sponse. :\ similar pathogcl1t:sis, but with variable targets 
.1l1d outcoml'S, pcrtains with all noncytopathic micro-
parasites: for example, hcpatitis (Fig. 2R) and cytomega-
lovirus (rig. 2D). 
~rom this pOilll of \'iew, Zinkernagel and Hengarrner 
had suggeskd in 1994 that the foremost therapeu tic ob-
jective under most circllmscances is to limit the extelll of 
the il1t~Dcred ccll targets, or in clinical terms to reduce tht' 
viral load and n:stricr its spread. i c,) This has since been 
accomplished in IIIV victims with zidovudine and pro-
tt:ilse inhibirors. Oncc a large targct is established, thc 
deliherate rcsurrcction of a strong CTL response could 
have the disastrous consequence of widcspread host cell 
killing. :\ hencr option under these circumstances might 
he tl1l' administration ofT cell-directed immul1oslIppn.'s-
sion in just the right amOUlH to prevent the CTL-medi-
ated desrructiol1 of massive numbers of host cells, but not 
SO much th.lt rUna\\il)' viremia would merei)' expand thl' 
target t(n arrack from a recovering CTL clone. Thus, the 
rherapnnic aims in an intractable l1oncYlOparhil patho-
gen infcnion would be ro predict, monitor, and cquili-
brate benl'flcial baLu1L"l's het\veen pathogen distribution 
and rill' ahsence of an immunopathologic ). cell response. 
The Organ Engraftment Objective 
Com parable anrigen/CTL halances mllSt be found and 
kept subk for successful transpiam.nion. The best chance 
to cstahlish a balance sekctively r;lVoring tolerance is dur-
ing the hrst few post-transplantation weeks, during which 
the maximal donor leukocyte migration provides the op-
timal conditions till' reciprocal exhaustion-deletion of the 
double immune response (Figs. 1, 3R). This one time 
only the window of opportunin' could be narrowed or 
dosed h\' so much prophylacric immunosuppression that 
clonal acri\'.lliol1 is sulwerted. To the exterH this were [0 
occur, later reduction of the primar\' over-treatment pre-
dicrahk wOllld lead ro recO\'erv of the indlcCfiveh- deleted 
, . . 
done wi th the cl inical consequence of delayed rejection (fig. 
.K:)." Ho\\'l'vl'I', the penal IV of too little immunosuppres-
sion during the critical early period may he irrevt'rsiblc rejec-
tion. III 2001, this dilemma, it was thought. could he 
addressed by application of one or both of the therapeutic 
principles depicted in com hi nation in Fig. 4." 
The hrst principle (shown alone in fig. 313) consists 
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Fig. 4. Protocol of .. tolerance friendly"' Immunosuppression mtro· 
duced at the University of Pittsburgh Medical Center. /o An antilymphold 
antibody Infusion before arrival of an allograft reduces the anticipated 
antldonor response into a more readily deletable range and allows 
maintenance treatment to begin With daily monotherapy to which other 
agents are added only for rejection. Weaning from the monotherapy may 
be possible later. The Inverted curve at the bottom shows the usually 
silent graft-versus·host (GVH) reaction shown more clearly In Figure 1. Tx, 
tra Ilsplantatioll 
nosuppression than [he amount needed 10 prevent 
irreversible immune-mediated damage. Because of histo-
compatihility and other conflJLll1ding parameters in the 
human population, sllch ideal immunosuppression in in-
dividual patients cannot be accurately predicted. \X'ith the 
sl'cond principle (recipient pretreatment), host global im-
l11une responsiveness (an be reduced by nonm~Dc1oabla[iyDe 
conditioning before arrival of donor antigen, thereby 
bringing the anticipated donor-specific immune response 
into a more easily controllable and dcletahle range (hg. 
4). The 2 principles have been combined in a practical 
regimen using J single large dose of an antilvmphoid an-
tibody bcfore transplantation followed by minimalistic 
post-transplantation tacrolirnlls monorhcrap\ \\'ith the 
illtent ofnentual weaning (Fig. ')). Satisbcwry results in 
liver (Fig. 6) and other kinds of organ recipients with 
reduced overall exposure to immunosuppression have 
been obtained., '.'. U<> 1\.' with the striking exceptioll ofliver 
recipients v,'hose chronic end-stage hepatic Elilure was 
clused. lw hepatitis C vi rllS (H CVr \;,; (sec next secrion). 
The frequency and extent to which drug weaning Cln 
be accomplished in hepatitis-free li\'er recipiellrs with 
such tolerance-bcilitating immunosuppressiol1 has yet ro 
be determined. Complete stoppage of treatment has hecn 
attempted in only a k\\ of these recel1t cases. However, 
the kasibilitv of liberation from immunosuppressive 
drugs is e\ident from observations of oLlr fi rSf 21 () liver 
recipients: 184 at the LJniversin' of Colorado (benveen 
1l)().) and 1980) and 26 at the University of Pins burgh (in 
early 1 9tl1). Thiny-hve (J 7(!'o) of the 21 () have now 
reached or passed their post-transplantation silver anni-
y1 ~p S1:\JZI.1 .\1\1) 1.1\" " 1\ 
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Post transplant year 
Fig. 5. An example of the strategy shown in Fig. 4. A woman with a 
hepatic hemangioendothelioma who was infused with 5 mgjkg antlthymo· 
cyte globulin (ATG, thymoglobulin) before liver all ograft revascularization. 
Tacrolimus (TAC) monotherapy was reduced from dally to every other day at 
100 days, and to once per week by 10 months. Treatment was stopped at 
22 months. She has been immunosuppression·free for 11/2 years Serum 
bilirubin and measures of hepatic parenchymal function have been nomnal 
throughout. Although enzyme levels have been stable, these have hovered at 
a high normal range or slightly above since a rejection at 6 months, which 
was treated with 1 g methylprednisolone. SGOT: serum glutamic·oxaloacetic 
transaminase, GG11' gamma·glutamyl transpeptidase. 
versal)' (Fig, 7). Thircy-rwo (15%) are srill alive from 24,5 
[0 35.7 posr-rransplanrarion years (mean, 27.1 .:!: 3.1 
SD), and .') died afrer 25 years of lung disease (# 42), 
widespread merasuses from colon carcinoma (# 82), and 
dr nOIJo HeV infecrion :"93). 
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Fig. 6. Patient and graft sUivival (above). and current immunosup· 
pression (below) of hepatitis·tree primary liver transplant recipients 
treated in Pittsburgll with the prinCiples of immunosuppression shown in 
Fig. 4, and exemplified in Fig. 5. Left: pretreatment was With an infusion 
of 5 mgjkg rabbit ATG (th ymoglobu lin) (n = 23), Right: pretreatment 
was With 30 mg alemtuzumab (Campath'!' ) (n = 38) 






















• fmmulltF!lKllpp["ED~"Dl·d j 
• o "'I! Free 
I Re-T.\ 
eD,.,h 
.. D DDK~ ., 
o 10 20 JO 
Post Transplant vea~ 
Fig. 7. The 35 patients from the first 210 who survived 25 years or 
longer after liver replacement at the University of Colorado (n ~ 184) or 
University of Pittsburgh (n = 26) The times on (red) and ott immuno· 
suppression (green) in individual patients are displayed in the horizontal 
bars. Note that 6 of tile 32 still·surviving recipients had retranspiantation 
11 to 28 years after the primary procedure. 
1m portamly, 16 of the 35 g uarter-cenrury survivots 
had periods of 3 to 31 years off immunosuppression, as 
indicated by the green portion of the horizonral bars in 
fig. 7, In 5 of rhese 16 recipients, immunosuppression 
was resumed, but not bel~lusc of breakthrough rejection 
ill any case. The reason for treatmenr reinstiwtion in 2 
parients was liver retransplantation necessitated bv intrac-
table biliary tract complications (#202 in Fig, 7) or be-
cause of HeV hepatitis (;q 25). A rhird recipient whose 
cyclosporine-based immunosuppression was stopped af-
ter 11 years was rccurned to rreatmenr () years laeer be-
cause of cadaver kidney transplantation (# 192), The ocher 
::. recipients who were as;'mpromaric and had rejecrion-
free biopsil's were restarceu on treatment because of pa-
tienr and phYSician anxiety (#64 and # I 05, in Fig, 7), 
The Price of Chronic Immunosuppression 
The consequences of a decision to resume ImmUIlO-
suppression wirhour a clear justificarion may nor be evalu-
able for years or decades, When a derailed accounr of our 
210 first recipients was published in rhe June 1993 issue 
of H FPI\TOIUC Y, q 50 (23%) of the original parienrs had 
survived for at lease a decade (maximum, 23 vears). How-
evn, 7 had died 1 to 11 years after rheir 1 orh annivers.u)I, 
leaving 43 (20,'5%). Rejection had nor caused any of the 
late deaths. Instead, rhe mosr common causes of death 
. . 
.. 
were hq),u iris, orher inFecri ons, malignanr neoplasms , 
and drllg-s~FtDcifiE side effecrs, The sa me parrern has been 
ap parel\[ in rh l' funh<:r shrinkaal' of survivors ben'veen 
1993 and 200') (from 43 ro 32) For reasons orher rhan 
rejccr ion. Chronic immun osu ppressio n clearly has been 
[he principal direer o r indirecr Gluse of lare mOITJli[y. 
Organ Engraftment in ReV-Infected Patients 
Alrhough [he im porrance of reducing or eliminaring 
long-renn immunos uppressio n is clear, when rhe colero-
genic sr r~uegFD depicred in Figs. 4 8nd ') \vas applied in 
Pitrshu rgh in HCV-inFecred li ve r recipien ts , [he resulrs 
fulflil ed rhe I <)94 prophecy of Zinkernagel and Hengarc-
n e r l~DF (scc earlier di sc ll ss ion). Flm, rhe lymph oid deple-
ri on caused vi rem ia. T hen, when later attemprs weee 
mad e co WC,1I1 from racrolimus monorherapy, rhe heavilv 
in fe 'red live r graFr was rargered bv recove rin g CTL, re-
sulring in early and severe recurrent HCV disease. Wi rh 
n:cognirion by Egbrcsad and Fung er al. ' of wha r had 
happcned, the expl8n ati on also was a ~Fparenr For rhe 
worldwide epidemic of HCV recurrence rhar was assoc i-
ared wirh rhe varioLis regimens of viremia-i nducin g h e~wy 
multipl e drug immunosuppression. 15·,-1 ,H Becallse srrong 
prophyh ct ic immun osupp ress ion cannor be adminis-
rered indefinircJy wirh ou t Faral co nseCjuenc '5 , sllch trear-
ment eve lHuall y musr be reduced. The co nsequent e n 
recovef\' was leading co wides pread des rruuion of in-
rccred allograft cells in rhe same way as with rhe weani ng 
of our kll1phoid-dcplctcd pari enrs. - \ 
In cOl1uas(. lighr bur co ntinuous double-drug immu-
nosuppression wirh racro limus and prednisone has al-
lowed rhe sy~ tem aric development of a relacive ly 
,l sympro mari c carr ier sra te: a sr,lbl e equilibr ium between 
HCV and eCs-s ~Fec iflc ( : I L. - \ Thus , rrear menr pro co-
cols rh ar minimize disease recurrence in H ' V-infected 
liver ;:dlog l D ~gr rec ipi ent" musr balance the de,ire ro reduct' 
imlllunosuppress ion or induce allorolerancc with rhe 
need [(l preve nt antiviral immunopathology. Curtailment 
of rh e epidemiologic implicarions of producing H CV-
carrier I'ecipienrs, and of rhe probability of insidiolls di s-
ease recurrence, will depend O il co ntainmenr of rhe viral 
load wirh ver to bc developed H CV-spec ifl c drugs. One 
ca ndi lLl[c i, th e prorcase inhibiror reccnrl y descr ibed in 
HI:I',\TUIOC Y by Reise r et a l. I \') 
Tumor Surveillance 
Rv rh~· late 1960" co nvincing ev idence exisred rhar 
imrlllillosuppressio n in orga n recipients could resulr in 
acci dental cngraFtment of donor malignancies , accele r-
<lred arow eh of [limor metastascs, or rhe development of 
" new malignancies (summ ar ized in I 11l , I 'li Because rhe 
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Fig. 8. The relation of organ-induced engraftment (right) to Classical 
models of spontaneous donor leukocyte chimerism-associated tol erance . 
recipients, liver rransp lam centers have become horbeds 
of onco logy research . Two rumors ha ve been of particuJar 
imeresr neo.use of th eir etiologic assoc iation wirh imra-
cellular microorga nisms: post-rransplanearion lympho-
proliFera ri vc disorders (PTLD) wirh rh e Epsrein-Barr 
virus, and heparocel lular carc in om;l with HBV. T he 
PTLD, mosr of which are 13 cell lymphomas, provided rh e 
flrst un eq uivocal proo F of immun e surveillance of a hu-
man malignancy when rhey disappeared after wirhdrawal 
oFT cell-direc ted immunosuppression KD~ 
T he possib iliry of preventing v iru~<lssoc iated rumo rs 
wirh vacci nes was de monsrrared lw C oggin , 1.arson , and 
Hilleman f D ~ wi[h prooF of prin ci pJ e srudies in primares of 
rhe SV Iii virus, and ex rended to humans 20 :'ea rs larer 
wirh rhe recom binane HBV vacc i n ~D trials. The HBV-
assoc iared heparoma scourge was virtua lly elimillared in 
immunized Asian popularions. I ' \ How rhc dlHi-HBV-
lnduced ant ibodies produced by the vacc ine interrelare 
wirh T ce ll immuniry has been rhoroughly srudied wirh 
LCMV I ., Jnd explained by Klellerma n. 1 .'i T he research 
a nd therapeUt ic opportuniries opened by rhese and o[her 
ohse rva[ions is too V:1 St ro dweJJ on here heyond empha-
sizin g thar the mechanisms of immun e reacri"iry and 
non-reacr ivirv ro rumors are rhe sa me as rh o~e of rran s-
p lama tio n. 
Autoimmunity 
T he chimerism-depend ent lllech;lIl isrns of nOll-reac-
riviry co aliograFrs, all of which depend on mobile leuko-
cvres , ca n be id enrincd in a conrinuum of classi cal 
tOlerance models rhar began wirh rhe obstTvarion bv 
Owen of mi xed bl ood ce ll chimerism in Freemartin e 1[-
tl eK .' ,md ended in J 992 wi th rhe discovery of microchi-
meris ill in li vc r and orher kinds of orga n recipiellts (Fig. 
8) . OF hisrorical imerest, Paul Ehrli ch recogniLed more 
dun a ceneury ago rhar a par ienr's ri ssues co uld be de-
sr l'Oyed bv an immunc system run amllck. Ehrlich's rerm 
\I.\IV.I \,,1) 1.:\1(1(1' 
of "horror auroroxicus IS [Odar's auroimll1une disease. 
He postuiatt'd rhar rhen: IllllS[ he mechanisms to prevel1l 
rhis hv .. a regllhror~D conrnvance as I'<.:r undt'-
,cribed." I I< In the comC'Xr ofimmullology descrihed ht'IT. 
the cOl1tri,'ancc that Ehrlich envisioncd consisted of thc 
mechanisms that have madc transplantation feasihle. 
A Need for Closure 
A coht'fclH proflle of immune function and gover-
nance klS emerged from the swdit's of transplantation 
,1Ild infectiol1 summarized here. Howcvcr, mt'chanisms of 
nonresponsivcl1ess other than the esscntial ones of im-
mune ignorance 11'.11,1 '" and clonal deletion (Iisred in 
Table 3) haw gencra[ed a large bod\ of hisroricll 1 'I and 
n:cent puhlications. I ·.' :;" In turn. these model-specihc 
and poorly undersrood alternarive mechanisms have be-
come t'lemt'nts of ft'curring immunological dogmas and 
theorit's, l-, assigning rhem essenrial roles in rransplanra-
lion rolerancL' justihable: Evidence of their exis[enct' de-
rives from phenolllena observed in experimental models 
in which rht' immune ,,"stem is drastically perturbed (e,g., 
under condirions ofh-mphopenial or the ;]migenic barri-
ers [0 rransplanralion are signihcantk weakened {c,g., 
transplantation across mmor histocompatibility 111 IS-
m<llche,l. To cOll1plcrl' the picture. it will be Ill'ct'ssary to 
lldiniti\'ek determine rhe condirions for the dl'wlopmenr 
of these phenoillena and to accurareh- assess rheir func-
tional signifiClllcc. 
Conclusion 
The article l'n ti tied "The Evolution of Liver Trans-
planrarioll" published 111 1')82 in HEI',\['()I(l(,\ con-
cluded "jrh the .,LltL·l11enr rlLlt what was 
inconceivable- \'('srerday, and barely achievable today, EFr~ 
rt'll bl'coilles rourille wmorrow." IS Li\'cr rransplancltiull 
proved ro he a prime t·:\.lll1ple. Thl' ~lccolllplishl11enr wa, 
more th~ln the ,tddition of the crucial centerpiece for rhl' 
rrearl11l'iH of orhClwise !erhal end-stage hepatic disease, 
howl'\'er. Liver rLlI1splanrarioll was frol11 the beginning, 
and will COnrinlle to be. an instrument of scientihc dis-
ClyDlq~D in multiple- helds, and above all in immunology. 
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fl11fl{if~llIK{EFnIli "D~-"DllDlll for ... --quiuhk :-'L'k',,'-I[O/l ofl..,l(\avcric ki~lrliDKy r .. -Dt·ipicllr~K 
1..\,\1,\ 1'IC;-,2'i-:.l(r',>-.\II-'i. 
,,- S1'.11'zl IT. (Jordon RD, T/ak i ... __ '\. Sla ... I.. hak S, hOr;lL11l1 i \', Bro/llll..-k H, c! 
,11. Lqttit.1hk- .dlncJtintl (lfv\.(Llft·ILtl organ,,: \\'i!l-! '1)1.."(.[<1i rd~qiDnElDlE1 lh~ 
lin'l". -J r.m ... pl.u;1 Prol fqpp;OM:gP1~1IFeK 
0:;:-;. \·I,aki ... :\, '[ od'i \. ''If;tl'/I IF. (hthoropil..-li\'T tl-,t)l:-.pi:l1lU[l()11 \\iIlI fnc' 
,T\'.Hiol1 ot·lll\.., ilF~tqiEFl- \l'\U l:.1\.1. ;\1l11 pllr~ 1DlI-;q:~:1EF:EFD-fq-EFDFOK 
'i9, 'Lil/ill. I'"do S. 1:1f11~1I I )c'l1\llri, .-'11, \·L'l1k,1I""alll,1I1.,,, R.I,lIl1 :\, f''' 
')()() t~F[- hUlllJll ii"t'[", kidll~:· .md p,lllnl·.I' {f;lll"'pbIlt;ui(lIL t ,1I1,-l'l ]l)H9:2: 
III()II-IOII, 
flO. , lILio').i,tlIlS U,Srarl! IT, luki .... :\, Ikl11l..'rri ... ,\1. KOl'lllo, \{ .. l·! ,d, Lj'LT 
kidl1\..·Y .. !lhl thOI.kll EF1~K!ll i r.tll"'pia(lr:llioll tllllkr f· t...: ~EFEFI \nn 'H1rt: ll)()(J: 
O1O:OtFD:;-KF{l~K 
i,l [til hlmIl~ r R, l~igl~D I), (;l!l)L·rruri .... (;, Il.u:", _I, !)\lII/Vlld.lhl ! I [r;ff"fDf~f:lll 
l.ltioll (·jlll'r ... p"-'IHkrL_:lw, .lllt' /\\'i ... l"Ill1pilil~iDr i "pi i I I in'!' ErKlfF~pilnrffEFl1D 
iill~D IIL'll\'" nlL·lhO<..h: ill dLT yyD~·itllK·feyy id;,lullg li~Dr khl..'\q __ 'JlIl'll[ Ir;!ll'plalll;l-
tillil. I gfl~"D·!1hlDiDbK Ardl E~hir I '>XH:Y-'): 12- -1_)0. 
h2, S(rollt. R\\ 1 :·nth S\', l Ffl~ I f I. ,\br...lIn'lmi II. ~EFidil y, j).lilkr'()l1 (;;\. 
SUi .. :u .... :-.,i"tli li\LT frall'pLl!1t..lliul) (rolll ,I liIDin~~ dono!' \() hli" '1111, \: I·ngl 
I "kd I ')'HI 522: I "0"-' '((-, 
() ~ ])r{)L,I ... ch ( !'. LlllOlid 1< \\·hiring[oll Pi l'i!I'-l!l'rll\\-',llll' IR. Itlkn ,·\1 
I ilhtlli" .II. -\)lf1lil,llHI!1 fit· rl,duL·L'lI-:-.ilt· II\l'l :r,llh)II'lIlh ,1\ ,pli! ~~rgfDh 
,ll!\ i I j.lr; I nil lil(Opic gral-l:-', .l!ltl 11\'1 ng rl-l.uni "'\..·gllh'll Ld rr,lIl'lll,lIlt ,. ;\ 1111 
~lfr~ ) qqEF:~ 1O:KFSu~P-~K 
(J'L \L(l/l II', I 1C'I1""ri, AI, .\lur,1',"" Ild,Lld \, I<icordi ( I ru"" \1. ("II 
/ll1~r;~1 iUIl .... -illlllt.:ri:-'l1l .. lIld ~ilEt ~!ElqlEgni·fKDK t,.lIlU.:1 I 9')2 I~vF·f ;;-Q-J'::'X2. 
();;. ".ell"!i TL I )clllL'[ri" __ \1, Tl"llL'dl.\1, i'dur,\\l' _" ]Zi,-o["lli ( , I Jd ... l.ld S, l'( ,Ii 
(.l·ll llli:-:r.llioll .IIHi '- ili111l ;-1~ln .lftn \\'\ll)L' -yFfDK~Iyll (Lltl .... pLlllt.!li(lll: rlh' hKlIi~ 
El~rKlr·tKklKKls{DfffD-l·Kel;D yy!ED~Dy l')q.':1 1!1-_1\-=)2. 
()(). ,\urll IT, lillklDrnIf~iD~ R yl1li~c[llEFl·;gli/ .. tti()jl ,1J1d 1l1i~rIlti{y11 III illllllll11I(\ 
.1Ild tEFl~·rKll1clKKDK "'" I fl~y 1 \ lnl 1 I.)l)}L,,),)l); 1 tl{)'::;_; q 1 ), 
r,- Y"m.l"b I , \\ .,,111(1., \ I I 1 (Jl1d.1 ",1',111.1 h." ", \ L,,' I,. \h il1l.1h,II',1 1 . ,', "I 
I ,i\lT I r.IIl'p1.IIlUIillil 1!"ff:~K1 right lohe ~rKlrDl )I'ilill .1 li\·II1:':' rcl.llnl dllll(11 
i 'r.lIl"f)j;llll.n ion 1 I)'J j:'::; -~ . 1,2-- \ 1.)0. 
hri. \\;[(h ... \1.B..lkT,K;ITTI.'!'I;,I_\LT\olll,l·.Shrv"duR, 1·1·(l\ltlidlll .... I,·I.d. 
Adult ii\ illS dUIlD!' linT [ull'pLltlLl! iOll u'lIlg.l ri~hI hq).li j, IlIh(' ·j'r,1I1"'-
piallLHi()!l 1l)9X;()(): 1.:; 1.1-1 ~ 1 (L 
h'l. ~imoI \, It,he" RA, Il.llll I\!. Shiftnun \11, ';II\\'al .\1, I uhc", VA, l'l 
,ii, oi~11l I"hc ii, 
'·l)N-ktl __ ). 
II. ~ilr/l '['t-, /i[lfDl"fllKl~lD11w 1·rKl!1ypilflf~eiyy[llylkiIE[lllD from J hiItorl~Itf f)'·: 
'[1Cl-(\\I,·. \,',11 tl1"l.· olDy-ilKKDyy~: I mJ111111o]ogy 2U()):, ._>),-)-2.)') 
-I. 1'1",11" ( I "oikc' C, yDKylI~hIllFK 1\""",, .I, \\'dl, 1-;1). (lLcll \\1, <:l ,<I, 
I)I-ntill( t 1(l[1 (It·(\-· \ ,,)-g:aiactth\ ftr;ll1It~·rKhlKK- ddi,-'il'IH pig" ...... \., 1l.·ll,-,-' .2()() ):2(H: 
,11,[ I 
SIb2 
., SI;lIlIIT, \1111'1"" \:, ,\hu IIIllIll'd ~ C"n 1,'\, :-.h''I,;ro i{, t:.:lllC.',IlII\, ,'l 
,11. qokqEF~t:niII- illlll11lllO'>lIppIL'",sion ItH org~lll trallsplKlllE~ejnnK L.lI1l'l'r 
200,:,1, I: 1 ~1fO· I 'i I 0 
"5, 1:'Shl',',ld 1\, IUlib .II, 1 l"llllHi, :\1. ,\lur:h, '.;, ~c>I K, H"" DC, ,'l "I, 
\ti..'chanj'rll-ha\,:d prinEi~Flt:D .... of iml11uno\upprt·<;:.ion for liver u,U1:.planLl-
fion ill H( '\' -!nft~lll·d p,ULCIH ..... Lih'r qr~lg1ypl 200-=); I I: 1.:;"·L)- 1.:\12. 
.f. K-yflE}f1~:mull~K :\uioll Pl.lIl for I i\'l'f Di .... ea .... t: Rc.\L'ar(h. In: i" .. uiollai J nsri-
lUI,', ofrktllh, '-JIll I)uh, \:0, EFD1I~:IIFzI lS. Dep,mrnenl ofHl'"llh ,Ind 
Human \tT\,iL'\..'''', 2004 (1 )l'll'l11hL'rj: I-I),), 
~~I I'r:1I1cwilb .-\, ea~iyD:l ~1K i'ortn KA, I'olimenll I. IhaLl I )r.trzl TE, 
·\lIgllll..'mn I d'li\'lT l-q~iKKDrllDilf l1.lI1 (AI Rl: it .... pLJ,I..-l' in the ulli, n'>l' of ill'P;Hic 
growrh l~litor:-KK Hll':\l"llil)(,' 19l}il;OM:~4~~""DDi-K 
h, SOIlI TF, I '''Ill'r 1';\, fDaIhlyyIf~i \:. LL',' IY, I,""dl WII. i'url1.ln1 C\'( I'h,' 
\.'tll'Cl of <.li;lhl.'((.::-. Illcllilu.., on ponai blood heparotrophi( t;1Ltor\ in dog .... 
Surg (;ynt.'lo1 EFh~in 19~~: l-IO:.:;;; ... tF-~EFOK 
Swzi 'II, I'onl'r KA, fDIislllwIl~i \:, 1'1Ifl),1I11 (:\X', l'on,,1 hqurotrophie 
b<.TOr.,>, di,lhc[i.::-. mdlitu:-. .tnd ;l(lItl' liver Ilrroph~ .. h~Dmt:rtroph~D .llld regt.:n-
I.:r.nioll. pllr~ E~yDfwlEFl ()h>"«"( 1lF-~: I '11 :o~l_F-uIFeK 
-S Sr.lrll '1'1, Dcm"tri, AI, \',111 Tlm,1 DH, ~kdillrl progress: li""r rr,'"Splal, 
r:llioll, \: 111,:1 I :-'kd !I',tr[ I 1<)1"1:.i21:11l1+l0:2: :Pan II' I'>W):521: 
I 1l')2· I IJ')<). 
~IFI \X'olql'llh"lrnL' (;1'\\', ()'( '"nllol' \1 kdsl. hilic, in ,".lcdi,:/ll mro~reII: 
\\'i(11 .'\pl'lI.d RcfcrCI1Ll' to I LIll"'plalll,uion. Bo ... ron: Linlc, Brown, l')()(); 
1-249. Tth' ~~D!l1mEFKKIilllll hl.,'ld in l.oJldoll ar (hI.:' CI BA HOll:-,e yyD~1KD" .Hrendcd 
h~D 2') ill\'J[n! pily'>il i,m'" ;wd ,>urgcOll\ (in(illding O[ LS, Kl'i(h Rt't.'m(:'Jl);l, 
.lIld J(l ... ~K:ph F. \1urr,lY). , .. :rhi(j'iL\, nK:li~iEFflD" kDKegiDf~K meJicd phdo\ophcrs, 
ju,lgc .... , ,llld fKlyy·~D<K:ryK 
SO Blfr~tKKDr \\T. !"Ill' L1W ,l.lld Illl·diL;ll <l<.h·.H1Cl .. ·~K Ann flllL'fll ]\ll'd f~FEF~~ 
1I~Ept!fDpl ~I: 1 '1-1 K S\'Illl'",illl1l on .".1cc!ical hhi" "I' till' AlllL'ric.ln ;,,,,,, 
i..i,l(loll ot P!JY\llLllh with prC,\CI1LHiol1\ h.\·: PI.:lL'1 \-lcdJ\,ar. Joshua 
l_l'<.krhtlI"S. '-h()!ll.\\ SUfI!. .tllLl \\ '.IHell Burger iyllhseqtllDnrl~D (:11 il'" i list ice 
of (he l 'nilnl .\{;l{\..',\ \uprl'llk (:Ollrt L 
HI, "ll'da\\',11" Pit '1 'hl' hcll.lvlor ,lIh1 t~ec of "kin K1r{El~r;lfts and ,..;kin hot1logra/I'" 
In ,"hhil', I \11.11 I iFDe:~:-;: I ~h·1 I)'). 
K2. ()Wl'1l RI1. lillll1tJllogl.'(h'fil \,I.)[l',<Cl/llCJ1CL'\ ot \'.I,,(ui,lr .tIlaqoIllOSl'S bt·\vl.'l"1l 
bovinc l\\-ilh. ~~-llDflCiD 1l)-f':;:1()2:-tOO-401. 
S,). Hillillgll.lm f~cI Hrvill I.. .\kd.l\\-ar PH. "I--yD-[fyDel~D ,h.quircd [Oln;lllu.'-' of 
t~FrtKKDigll ,:clk ,",,[{lire I 'IS.): 1-2:()()j-60(1, 
S'L ~ilill 1~1K [Irl'hn R ['. \Ul'-'--·...,..,t"U] ... kill hllnu~r~lits ;1 t"t L' I thl' ,ldministLlIion 
of high l!n .. agt.· \: radi.lriof1 I1fl~1 hlf11EFfEFgnll~ bonl' marro\\'. J :\.n] Callen 
Imt lDhD1:f~:fEFOR-1EFODFI 
~DI ,\lllll,lI 11, \k"illil', 1)""1111111 (;.1. Iklh .In, I, .. \\ialte, C\\, Bl'llok,' 
\is, l'! ,11. :--'llH.ly of [r.IIl'>plaIlLl!io{l imtllunity .It'tl'f rOLl] hody ilr.h..iiatioll: 
(I i 11 il.t1 ,\I1d t''\pl'rillll'IHal 11'\\ l'st ig.lt ion, Su f"~yKDr:· ll)()():4H:2-.2- 2R..;,. 
Xb. Hdmhu,l'C! .I, \,I\.,se .1, ll'l"nlL'll, Tubiall,] \1. l.alann,' C\1. .-\11 [Oil1l' B, 
l·t ,d. Tr;111"111.1I11,uioll of ,\ killtll': hlT\'Io'l'Cll IHlIlIllOlH)Z!'gotii.. t\\'ins ,lfrcr 
irradiatioll ot'r1w n:u.:i\lT. (, IO(){.! ftJllL'rioll ,It [hc' fourth monrh, Press(' J\11'd 
f<FDi<F:EI~: I ~-fI I "~D1K 
~ Hill1lhurSL'l I, \',1\""1, (,mllier ,I, ,\[lInr ,I. L.Ia,,"l' Cl. Hopper I. [I, 
Rl'llal homotr.ln"pLlIlLllidll in 1ll,1Il aftl'r r~-hji~eioll of rill' rt>cipic'IH. Am I 
.\ll,d jl)(l'::: FO:epI·~-e-lK 
KH, Kw,,\ R, l.q!raill \\. 1\1.l[hc (I, \:l'Jl'Y R, CKl1niKKD~ .\'1. H0l11olog.0l1'> human 
k illlll'\ 11",\11 "pl.lIl r.ll inn: l'X 11tTil'lli..·l' \\ i [It II>i~ lUI it'IH\. p( ):"lgrctd .\ ted.l 1l)()2; 
FM:~~u ;;51. 
Xl), t :alnl" RY, lnhihition ofdll' rl'jl'dioll of I"l'Il.ll hEFll1o!-!raft~ ill dogs h:' purilll' 
.Ula]og;lIl' .... I'r,tll ... pLlI1t Bull 1<FE1!:O~:Ij·Di-F-iell 
'II) \lurr:1\ IF. \klllJiJP, Il.lrri,,," IH, \x'iI,on RJ:. llal11lllin (;J,l'rolongcd 
,'>ul'\'iva] ot Illilll,1I1-kidnl": 110Ill()gLdis h!- illlIllUll()SUpprn,>i\c drug tlwr-
1'1"" " Lngl J \ Ic-d I %Ki:K~i>p: 1.\ I ~-fKlODI 
'II. Hopl'w,,11 I, (".Inl' KY, l)",\\i,k I Th,cl' L'liniL .• 1 ,·:1se' 0'· r,'Il:11 [':10\1,1.111' 
[.Itron, III \kd I 1')("1:1:11111.\. 
l}2 '-'hl\'in S, Stroher S, hlk ... I., K.lplan H\. InduL'liol1 OfSpCLitll: li ... "uc trall"-
plantatio1l [pkr;Hl,-C lI .... int: t'r.ktiollJtl.:d [Ocd i~Dmplwid irr;ldl~l!inn in .ilhdr 
micl': 1EF11~·-ft:rm "ur\'iv.l1 ofazfEF~lKDnciE hOIll' /11.lrrow and skin gLlfrs. J Fxp 
\lL,d lDl~~ 1·,i>:I'IIH, 
H EPA II 1I ()( ,y, ~d"Dylrn 2()()h 
1)5, Udsud S"l, :"'.h.hs l )H. Rl'u)Jl,qitll{IOn wlrh "YIl!!t"lll'il plu\ .1I1()gcll\..'il (II' 
\l'IH)g(,l1l'ic bUllc marrow kad" IU .... pcl.·iflL acu:pl.lllll· o(,dlogr:\!'[:- ()f XCIlO-
~rIlttDI !\llmlle I Df~h;-IEF;: lC,H·I-(), 
\)--t. ph~lg"Ilhi \" ~Ildl:oK 1 )Il. \1ixcd I ... hitllt'l j'>lll and pnnUlJi,..'nr "'f)l:-.. i!l1. tram,pLm-
tJliOIl wkraJ1\,.:t' induced by .l IWI1-l<.-r11al prcp,u,Hi\-t' rcgimen. I Lxp ~ kd 
1'10'), I (,'):-1 '1,\- ~l 2, 
'i'l. (:olsol1 1'\" Li H, Boggs SS, I',mtnl' I'D, John""1 P(:, lids lad ST. [)ur"hk 
llli\(:d .1JlogL'nc'il- I--hiflliri~l1l ,md (ult-ranee b: .1 non-lcthJI radiatioll-hast'J 
c,wrcclllct!\l' "pproach . .I Iml1l11l1ol 1 ')')6: I '; ~:OpO1DIOoO<gI 
')b, ~lnrh R, Yll C \X'agl1l'rlL. IlcL'g HJ, "ash It"., !-;il'lll HI', "I,d, Stahle 
mi'\cJ hCfll,ltOpoit'll\..' L·hillh.Ti,m ill DLA-idl..'nri(JI li[t<.:rrn.lll..' dog" ~jyIlD11 
"uolerll.ll total body irr,l.Jiarioll bet(Hl.' ,tnd ph.Hlllal"ologicai immunosllp-
prl":-. ... ioll clfkr marrnw rrall~pieltaliEFflK BI(loJ 199--";x'):J04i)-,)O"S4 
IF~ Thom, .. , .11\1. E"khorf DE. C'>I1<reras II. Loh,l\hL'\'sh AI,. Huhhard WI, 
\loorlIK, "[ .d. Durab'" donor,spl'cific T ,md Ii ,ell rokl:m,l' in rhnlLs 
mdl.lqUl':'> IIIthlCt.,d with piKKqill·Ilf1~pbl1tatiEFn .lnti-l [),) ill1llllllh){().tlJ ,1I1d 
,-il'oxy:-.pcrgllal i n. 'l·ransplanrari( In 2000;()9:2·-I"- .. 2 '::;{)5, 
"~Di \\ l'kn1c -I', \ykc ... .\ 1. A.1ixc.:d l-himc[';,>m as all ,1ppro.ll h h)l' I hl' indul rion ot 
lransphllrarilHl rok·rann'. qran~planlarion Il)!.)\):()X:4-'::'()-4(1-. 
q(). ('j)\imi AH, Sach ... OH. 0.1i\cJ ehillli.:ri ... rn ,m..] [Llll'>f1\al1urioll [(lln,IIKc. 
'I LHl\pbnu(ioll 2(}(); ... ;;-:D:lFKE:;_9·~EFI 
I (HI. Slim.! Tl:: .. l lLl11eui, AJ, TruL," \1, lZalllo, f-j, I.el'\ i\, Ruden \\',-\, II ,.1. 
>'I\'QCl11iL ,--hil11u-i"'l11 ill Illllll.ln fl'male r\..'l ipilK:nt~ \)f null' lin'!''', 1,ll1li..'[ 
I DF<FO:K1Dll:e~EI·fD--
I II I. \r,ll'I.l '1'1, llcllle'trl\ AJ, TruLeD :-. 1. Ricordi C, I khud S, T,'I,I.,aki 1'1, er ,.1. 
ell i11l1.'risIll af[I,T I i\·l.T Eran~pbllta{ ion !()f" f)-Vl" I\' gl~·1K ogert S(()r.lgc dl~lDa"DlD 
:lI1d TIp" I Caliche,', <lise:he. :,; Fngl J ~K1cg 1DFDn:IFOe:-4"~fiF 
102. ~tKlrzz TF, Dc'Il11'tri:-. AI. -I 1'l1((O'\1. Zl.'('\·i ,-\, o~lfllly H, "['t..'f,I.",\ki P L'].lL 
E~hifle:rism .lIlt! dlflEFf"··~pE:eihE nlfecaEtiyDi[~- 2- to ~EF !'car:- ,1([l'l" kidlli.."\' 
,tllntLllhl)I,II1Lni()I1, qrall~plKlle;l1iEFn llFqKF~p": 1.2 -O-1O:-~ 
1 (J.1" Scn/l TE, L )t'fl1l'tris AJ, TLt1l\pialllatioll miln-tlll'lcs: \'invnl wirh Olll'-
,llld lWl)" way p~nKlI-ligflly of [()il'LlnLl..', J A \'1:\ ll)q., :O~ P:u;E1-tyc~F 
:(14. I'I/.l'pinrk," D, Tholll;1' Ul. \)Uri1Jlll !g~1K h,hel I Lse uf.l prob,' 1(1 
rcpeal Sl.'YUl'lht' of thl..' Y Ch1U11l0S01lH' t()r dl'ti.."lliOIl oj" host d·IL .... ill ptD~ 
I q1hcra! hlnod tlt" honl' [1l,\lTpW tr,1I1.'>pL11ll rl..'i..ip'Cll(:-, Am J (·Iill !\lIho1 
19') I :DF~:OM 1-206, 
I ()=), ,')(hli[( H r, H undrie .... t:r I, Ringe H, michzfglKl~q It [-)ollor -t\ pl.: 1ll1~ rni..,hi 
!11crislll ,t:":-tlCi.ltt,d with gr.lfr l'ejl.'Llioll Light H',a .... It·f,'r ]I\'t.'[ lr.ln"pLIIlt.l-
rion, N bl1~lK! ,\-led I 'I'i'i:'.\():(14(,·6 c j -. 
1116, fylfrlil1~filln \\ll,lailer".l', f:,',hlle,.!II, I'u"]k,,,>, TnIL,(l \1 "(l'OU 
\1. l'r al. yliI--q{lt"hill1cri~m 1111"i..,d ro l'yroroxi..: I' 1.\·lllpho(Yl\..' t'lIlKriulul 
llIIrCSPUIl"i\t'llt'\\ (clolla] If!llKDrg~-:f III a [ok-LIlli rt'lul !rJ,IlSI)l.lll[ rn If'icllt 
I rallsplanrarion 1DFDF~RlF:1 !·D~·ff~pK 
10-. yu-Dnod~I p~hh ... nH. Chimcl'l"m ,1Ild [[;ll1\pl.lIlt.nioll [01<.'1'.1111.:,:, ,--',lll""',md 
dkcr.lllllllUIl,,1 I "clal 1- 1'1'1(,: 1O:~e4-DiheI 
1 EF~ Bll~flyKKDF1 :\, 1\:.11'\011 T(" '\-ioni" PI, \X'(I()d f\:J _ [)ollor-rl'ciplt'111 mien)\.. hi-
tlll'ri\1ll ,lfld [Ok-r,lIlLt' illdtktioll, l-r~lnypfgfeKl[iEF11 I ()t)(d) I: I ~EF-! -. 2. 
! ot). ~-1ilkr J. "1-nill·' ... · J,\l, Fsqul"ll,lIi \'. Tov.'ard [ok-LIne .. ' [0 human org.1I1 
lLlil\pLl111\, J t~·yy ,ldJi(ioJ1JI L-urnllarii..'\ ,lI1J ljlk"lioll.". l"r.lll .. pl.!IHLuiol1 
211()4: -~:DF"EF"FD1OI 
I III. 1'0 \, !lei" ILk A, j:g~n 1\lll, Ilinkc'i A, Rohd,' f'. i'rschcr I" l't .d, Till' 
(lillCtiolUI 1't:ic\';U1LT of pa .... '>l..'ngcr Icuklll\'lt· ... ,lllli lllicrEFlhiml:Dri~11l fOI 
heart .dlogr"t'r ,\CCl'pLlllce in thl.' rat. Na(Url' .\ kd I iKFEFEF~-F: 1.2')'::-129-. 
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